.Our team currently know that Takeda is wishing to discover a road to the FDA for epilepsy medicine ...
.Immunology biotech VBI Injections is turning precariously close to the defining moment, with progra...
.It's difficult to muscular tissue in on a space as affordable as immunology, but Celldex Therapeuti...
.Boehringer Ingelheim is providing to $1.3 billion for Nerio Rehabs and a preclinical invulnerable g...
.Ventyx Biosciences' Crohn's ailment medication did not aid people achieve remission in a phase 2 tr...
.Knowledge Therapies' period 2 SHINE trial has actually taken a few of the gloss off the Alzheimer's...
.Bristol Myers Squibb has actually had a whiplash change of heart on its own BCMA bispecific T-cell ...
.Charles Baum, M.D., Ph.D., that supervised Mirati Therapeutics' $ 5.8 billion purchase to Bristol M...
.After reaching out to more than 200 companies to partner a Tourette syndrome treatment that showed ...
.Novartis has possessed some misfortune with bispecific antitoxins previously, but judging by the ph...